Literature DB >> 22262855

Met kinase-dependent loss of the E3 ligase Cbl in gastric cancer.

Andrea Z Lai1, Michael Durrant, Dongmei Zuo, Colin D H Ratcliffe, Morag Park.   

Abstract

Strict regulation of signaling by receptor tyrosine kinases (RTKs) is essential for normal biological processes, and disruption of this regulation can lead to tumor initiation and progression. Signal duration by the Met RTK is mediated in part by the E3 ligase Cbl. Cbl is recruited to Met upon kinase activation and promotes ubiquitination, trafficking, and degradation of the receptor. The Met RTK has been demonstrated to play a role in various types of cancer. Here, we show that Met-dependent loss of Cbl protein in MET-amplified gastric cancer cell lines represents another mechanism contributing to signal dysregulation. Loss of Cbl protein is dependent on Met kinase activity and is partially rescued with a proteasome inhibitor, lactacystin. Moreover, Cbl loss not only uncouples Met from Cbl-mediated negative regulation but also releases other Cbl targets, such as the EGF receptor, from Cbl-mediated signal attenuation. Thus, Met-dependent Cbl loss may also promote cross-talk through indirect enhancement of EGF receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22262855      PMCID: PMC3318713          DOI: 10.1074/jbc.M112.339820

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

Review 1.  Cbl and human myeloid neoplasms: the Cbl oncogene comes of age.

Authors:  Stephen C Kales; Philip E Ryan; Marion M Nau; Stanley Lipkowitz
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

2.  Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion.

Authors:  Yoshinari Asaoka; Motohisa Tada; Tsuneo Ikenoue; Motoko Seto; Mitsuho Imai; Koji Miyabayashi; Keisuke Yamamoto; Shinzo Yamamoto; Yotaro Kudo; Dai Mohri; Yoshihiro Isomura; Hideaki Ijichi; Keisuke Tateishi; Fumihiko Kanai; Seishi Ogawa; Masao Omata; Kazuhiko Koike
Journal:  Biochem Biophys Res Commun       Date:  2010-03-21       Impact factor: 3.575

3.  Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.

Authors:  Hideki Makishima; Heather Cazzolli; Hadrian Szpurka; Andrew Dunbar; Ramon Tiu; Jungwon Huh; Hideki Muramatsu; Christine O'Keefe; Eric Hsi; Ronald L Paquette; Seiji Kojima; Alan F List; Mikkael A Sekeres; Michael A McDevitt; Jaroslaw P Maciejewski
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

4.  CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases.

Authors:  Yi-Hung Carol Tan; Soundararajan Krishnaswamy; Suvobroto Nandi; Rajani Kanteti; Sapana Vora; Kenan Onel; Rifat Hasina; Fang-Yi Lo; Essam El-Hashani; Gustavo Cervantes; Matthew Robinson; Han-Shui Hsu; Stephen C Kales; Stanley Lipkowitz; Theodore Karrison; Martin Sattler; Everett E Vokes; Yi-Ching Wang; Ravi Salgia
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

5.  Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer.

Authors:  Marisa G Ponzo; Robert Lesurf; Stephanie Petkiewicz; Frances P O'Malley; Dushanthi Pinnaduwage; Irene L Andrulis; Shelley B Bull; Naila Chughtai; Dongmei Zuo; Margarita Souleimanova; David Germain; Atilla Omeroglu; Robert D Cardiff; Michael Hallett; Morag Park
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-17       Impact factor: 11.205

Review 6.  Crosstalk in Met receptor oncogenesis.

Authors:  Andrea Z Lai; Jasmine V Abella; Morag Park
Journal:  Trends Cell Biol       Date:  2009-09-14       Impact factor: 20.808

7.  c-Cbl and Cbl-b act redundantly to protect osteoclasts from apoptosis and to displace HDAC6 from beta-tubulin, stabilizing microtubules and podosomes.

Authors:  Enkhtsetseg Purev; Lynn Neff; William C Horne; Roland Baron
Journal:  Mol Biol Cell       Date:  2009-07-29       Impact factor: 4.138

8.  Met gene copy number predicts the prognosis for completely resected non-small cell lung cancer.

Authors:  Katsuhiro Okuda; Hidefumi Sasaki; Haruhiro Yukiue; Motoki Yano; Yoshitaka Fujii
Journal:  Cancer Sci       Date:  2008-11       Impact factor: 6.716

9.  MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients.

Authors:  F Cappuzzo; P A Jänne; M Skokan; G Finocchiaro; E Rossi; C Ligorio; P A Zucali; L Terracciano; L Toschi; M Roncalli; A Destro; M Incarbone; M Alloisio; A Santoro; M Varella-Garcia
Journal:  Ann Oncol       Date:  2008-10-03       Impact factor: 32.976

10.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Authors: 
Journal:  Nature       Date:  2008-09-04       Impact factor: 49.962

View more
  11 in total

Review 1.  Role of E3 ubiquitin ligases in gastric cancer.

Authors:  Ya-Chao Hou; Jing-Yu Deng
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

2.  Four Immune Modulating Genes in Primary Melanoma That Predict Metastatic Potential.

Authors:  Jennifer Erdrich; Kristel Lourdault; Alex Judd; David Kaufman; Ke Wei Gong; Melanie Gainsbury; Nan Deng; Wonwoo Shon; Richard Essner
Journal:  J Surg Res       Date:  2022-08-05       Impact factor: 2.417

3.  Low expression of the E3 ubiquitin ligase CBL confers chemoresistance in human pancreatic cancer and is targeted by epidermal growth factor receptor inhibition.

Authors:  Brian E Kadera; Paul A Toste; Nanping Wu; Luyi Li; Andrew H Nguyen; David W Dawson; Timothy R Donahue
Journal:  Clin Cancer Res       Date:  2014-10-27       Impact factor: 12.531

4.  c-Cbl Expression Correlates with Human Colorectal Cancer Survival and Its Wnt/β-Catenin Suppressor Function Is Regulated by Tyr371 Phosphorylation.

Authors:  Sowmiya Kumaradevan; Shin Yin Lee; Sean Richards; Chimera Lyle; Qing Zhao; Umit Tapan; Yilan Jiangliu; Shmyle Ghumman; Joshua Walker; Mostafa Belghasem; Nkiruka Arinze; Angela Kuhnen; Janice Weinberg; Jean Francis; Kevan Hartshorn; Vijaya B Kolachalama; Daniel Cifuentes; Nader Rahimi; Vipul C Chitalia
Journal:  Am J Pathol       Date:  2018-07-17       Impact factor: 5.770

Review 5.  E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy.

Authors:  D Jafari; M J Mousavi; S Keshavarz Shahbaz; L Jafarzadeh; S Tahmasebi; J Spoor; A Esmaeilzadeh
Journal:  Clin Exp Immunol       Date:  2021-01-10       Impact factor: 5.732

6.  Induction of c-Cbl contributes to anti-cancer effects of HDAC inhibitor in lung cancer.

Authors:  Tzu-Tang Wei; Yu-Chin Lin; Pei-Hua Lin; Jin-Yuan Shih; Chia-Wei Chou; Wei-Jan Huang; Yu-Chih Yang; Pei-Wen Hsiao; Ching-Chow Chen
Journal:  Oncotarget       Date:  2015-05-20

7.  c-CBL regulates melanoma proliferation, migration, invasion and the FAK-SRC-GRB2 nexus.

Authors:  Minakshi Nihal; Gary S Wood
Journal:  Oncotarget       Date:  2016-08-16

8.  Met-HER3 crosstalk supports proliferation via MPZL3 in MET-amplified cancer cells.

Authors:  Yaakov E Stern; Abdulhameed Al-Ghabkari; Anie Monast; Benoit Fiset; Farzaneh Aboualizadeh; Zhong Yao; Igor Stagljar; Logan A Walsh; Stephanie Duhamel; Morag Park
Journal:  Cell Mol Life Sci       Date:  2022-03-05       Impact factor: 9.207

Review 9.  Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance.

Authors:  Huizhen Wang; Yida Lu; Mingliang Wang; Youliang Wu; Xiaodong Wang; Yongxiang Li
Journal:  J Mol Med (Berl)       Date:  2021-01-03       Impact factor: 4.599

10.  c-Cbl mediates the degradation of tumorigenic nuclear β-catenin contributing to the heterogeneity in Wnt activity in colorectal tumors.

Authors:  Moshe Shashar; Jamaica Siwak; Umit Tapan; Shin Yin Lee; Rosana D Meyer; Paige Parrack; Josenia Tan; Fatemeh Khatami; Jean Francis; Qing Zhao; Kevan Hartshorn; Vijaya B Kolachalama; Nader Rahimi; Vipul Chitalia
Journal:  Oncotarget       Date:  2016-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.